AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution

Trump moves to revoke hundreds of federal grants awarded to Harvard—a trove of biodata may be lost in the feud

In the ongoing escalation of the feud between Harvard University and the Trump White House has imperiled hundreds of research grants at Harvard’s medical school.

May 23, 2025

Vol.51 No.20

By Claire Marie Porter

Cancer Policy

Harvard sues Trump administration over international student ban

Harvard University has sued the Trump administration a second time since the start of the ongoing feud between the university and White House.

May 23, 2025

Vol.51 No.20

By Claire Marie Porter

Cancer Policy

Legislation to increase access to breast and cervical cancer screening introduced in the Senate

Legislation aimed at increasing access to breast and cervical cancer screening was introduced May 22 in the U.S. Senate. The bipartisan Screening for Communities to Receive Early and Equitable Needed Services, or SCREENS, for Cancer Act would reauthorize the National Breast and Cervical Cancer Early Detection Program, or NBCCEDP, for fiscal years 2026 through 2030.

May 23, 2025

Vol.51 No.20

Cancer Policy

Harvard amends lawsuit against Trump administration, includes additional defendants and funding cuts

Harvard University filed an amended lawsuit against the Trump administration, seeking to add two more federal agencies as defendants and to address the administration’s widening efforts to cut the university’s federal funding—now targeting over $2.6 billion and all future grants.

May 16, 2025

Vol.51 No.19

By Claire Marie Porter

Clinical Roundup

Breast implant closes reconstruction gap for patients after mastectomy

Johnson & Johnson MedTech on May 13 announced the U.S. launch of MENTOR MemoryGel Enhance Breast Implants, filling a critical gap in comprehensive breast cancer care for women who have undergone a mastectomy.

May 16, 2025

Vol.51 No.19

Clinical Roundup

Incidence rates of some cancer types have risen in people under age 50, NCI study shows

Researchers at NCI have completed a comprehensive analysis of cancer statistics for different age groups in the United States and found that from 2010 through 2019, the incidence of 14 cancer types increased among people under age 50.

May 09, 2025

Vol.51 No.18

AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution

YOU MAY BE INTERESTED IN

Trump moves to revoke hundreds of federal grants awarded to Harvard—a trove of biodata may be lost in the feud

Harvard sues Trump administration over international student ban

Legislation to increase access to breast and cervical cancer screening introduced in the Senate

Harvard amends lawsuit against Trump administration, includes additional defendants and funding cuts

Breast implant closes reconstruction gap for patients after mastectomy

Incidence rates of some cancer types have risen in people under age 50, NCI study shows

Renew today!

Subscriber content

Never miss an issue!

Login